Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB)
Wedbush restated their outperform rating on shares of Nuvation Bio (NYSE:NUVB – Free Report) in a research report report published on Thursday morning,RTT News reports. Wedbush currently has a $5.00 target price on the stock. Several other equities analysts also recently commented on the stock. HC Wainwright lowered their price objective on shares of Nuvation […]
Wedbush restated their outperform rating on shares of Nuvation Bio (NYSE:NUVB – Free Report) in a research report report published on Thursday morning,RTT News reports. Wedbush currently has a $5.00 target price on the stock. Several other equities analysts also recently commented on the stock. HC Wainwright lowered their price objective on shares of Nuvation […]
